1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)" is currently closed and not accepting applications.
Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS). Supports the commercialization of tissue chip systems with a focus on miniaturization and automation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-TR-26-004: Notice of Extension for RFA-TR-23-017 "Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)" Notice of Extension for RFA-TR-23-017 "Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)" November 22, 2023 - Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed). See NOFO RFA-TR-23-017 .
National Center for Advancing Translational Sciences ( NCATS ) The purpose of this Notice is to inform applicants that effective immediately the National Center for Advancing Translational Sciences ( NCATS ) is extending RFA-TR-23-017 Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed) by one Council round.
Due to the extension, the following dates will be added: New application due date: September 4, 2026 Renewal/Resubmission/Revision (as allowed): September 4, 2026 Scientific Merit Review: October 2026 Advisory Council: January 2027 Earliest Start Date: April 2027 Expiration date: September 5, 2026 The following sections of the NOFO have been changed: Part 1.
Overview Information/Key Dates Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date February 22, 2024 February 22, 2024 Not Applicable June 2024 October 2024 December 2024 February 24, 2025 February 24, 2025 Not Applicable June 2025 October 2025 December 2025 February 23, 2026 February 23, 2026 Not Applicable June 2026 October 2026 December 2026 Expiration date: February 24, 2026 .
Revised to read (changes shown in bold and italics ): Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date February 22, 2024 February 22, 2024 Not Applicable June 2024 October 2024 December 2024 February 24, 2025 February 24, 2025 Not Applicable June 2025 October 2025 December 2025 February 23, 2026 February 23, 2026 Not Applicable June 2026 October 2026 December 2026 September 4, 2026 September 4, 2026 Not Applicable November 2026 January 2027 April 2027 Expiration date: September 5, 2026.
All other aspects of the NOFO remain unchanged. Please direct all inquiries to: Program Officer, Office of Special Initiatives National Center for Advancing Translational Sciences Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Nonprofit organizations, including academic institutions and research organizations. Confirm the full requirements in the official notice before applying.
The published deadline was November 16, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed) is funded by National Center for Advancing Translational Sciences (NCATS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleDRL's Advancing Labor Rights in the Garment Industry opportunity (DFOP0019477) offers exactly $986,500 — floor and ceiling identical — for a single 24-month award. Eligibility is scoped to countries with signed Agreements on Reciprocal Trade with the United States, and Bangladesh is explicitly excluded. That design tells you more about the program than the funding amount does.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read article